FABP4 and neoplasm: Previous studies report that adipocyte-derived FABP4 can act as a paracrine/endocrine signaling entity to promote tumor progression in several different types of cancer arising adjacent to neighboring adipocytes (ovarian, prostate, and breast) [192,193].